2762 -- To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act. | Poliscope
To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act.
vs 7,255 other HR bills in the 110th — cohort avg 47d
Summary
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
Lobbying filings that explicitly cite this bill (45)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
-H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions;
-H.R. 2349/ S. 1413 "Uterine Fibroid Research and Education Act of 2007", To provide research and education with respect to uterine fibroids, and for other purposes, regarding all provisions.
Client expense: $1,440,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
-H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions;
-H.R. 2349/ S. 1413 "Uterine Fibroid Research and Education Act of 2007", To provide research and education with respect to uterine fibroids, and for other purposes, regarding all provisions.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Emergency Management Agency (FEMA), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
Cited source text, amounts, lobbyists, and targets
H.R. 2762/S. 1494, Special Diabetes Programs Reauthorization Support entire bill: Extends the Special Diabetes Program for Indians at the Indian Health Service and the Special Statutory Funding for type 1 Research at the National Institutes of Health each for 5 additional years and increases funding for each program.
Client expense: $145,500 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H. R. 6133, Medicare Improvements for Patients and Providers Act of 2008.
Support Sec. 303. Extension of Special Diabetes Grant Programs: Extends the Special Diabetes Program for Indians at the Indian Health Service and the Special Statutory Funding for type 1 Research at the National Institutes of Health each for 2 additional years. Additionally supported Sec. 185 provision to addressing health disparities.(Previously H.R. 2762/S. 1494)
Client expense: $335,500 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Emergency Management Agency (FEMA), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
Cited source text, amounts, lobbyists, and targets
H.R. 2762/S.1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians
H.R. 7141, Stem Cell Research Enhancement Act of 2008
Client expense: $30,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Diabetes issues
H.R. 1424, Emergency Economic Stabilization Act of 2008 S. 1576, Minority Health Improvement and Health Disparity Elimination Act
S. 2479, Catalyst for Better Diabetes Care Act of 2007
S. 2742, National Diabetes Coordinator Act of 2008
S. 2983, Diabetes Prevention Access and Care Act of 2008
S. 1494, Reauthorization for special diabetes programs for Type I diabetes and Indians
H.R. 2210, Diabetes Prevention Access and Care Act of 2007
H.R. 2762, Reauthorization for special diabetes programs for Type I diabetes and Indians
H.R. 3544, Catalyst for Better Diabetes Care Act of 2007
H.R. 4836, National Diabetes Coordinator Act of 2008
H.R. 2922, Preventing Diabetes in Medicare Act of 2007
H.R. 3014, Health Equity and Accountability Act of 2007
Client expense: Not reported · Firm income: $50,000
Cited source text, amounts, lobbyists, and targets
-H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions;
-H.R. 2349/ S. 1413 "Uterine Fibroid Research and Education Act of 2007", To provide research and education with respect to uterine fibroids, and for other purposes, regarding all provisions.
Client expense: $1,440,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Reauthorization of the Special Diabetes Program for Indians and the Special Statutory Funding Program for Type 1 Diabetes research, through S.1494 and H.R.2762, bills to amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians, or through Medicare legislation taken up in the House and Senate (HR 6331; S. 3101).
Client expense: Not reported · Firm income: $30,000
Cited source text, amounts, lobbyists, and targets
-H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions;
-H.R. 2349/ S. 1413 "Uterine Fibroid Research and Education Act of 2007", To provide research and education with respect to uterine fibroids, and for other purposes, regarding all provisions.
Client expense: $1,500,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Diabetes issues
H.R. 1424, Emergency Economic Stabilization Act of 2008 S. 1576, Minority Health Improvement and Health Disparity Elimination Act
S. 2479, Catalyst for Better Diabetes Care Act of 2007
S. 2742, National Diabetes Coordinator Act of 2008
S. 2983, Diabetes Prevention Access and Care Act of 2008
S. 1494, Reauthorization for special diabetes programs for Type I diabetes and Indians
H.R. 2210, Diabetes Prevention Access and Care Act of 2007
H.R. 2762, Reauthorization for special diabetes programs for Type I diabetes and Indians
H.R. 3544, Catalyst for Better Diabetes Care Act of 2007
H.R. 4836, National Diabetes Coordinator Act of 2008
H.R. 2922, Preventing Diabetes in Medicare Act of 2007
H.R. 3014, Health Equity and Accountability Act of 2007
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 2762/ S. 1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
H.R. 7141, Stem Cell Research Enhancement Act of 2008
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Cited source text, amounts, lobbyists, and targets
**see addendum page S. 1494/H.R. 2762 - To amend the Public Health Service Act to reauthorize the special diabetes programs for Type 1 diabetes and Indians under the Act, Funding of Type 1 Diabetes
***, no specific bill(s), Artifical Pancreas, Critical Path
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
Diabetes issues S. 1576, Minority Health Improvement and Health Disparity Elimination Act
S. 2479, Catalyst for Better Diabetes Care Act of 2007
S. 2742, National Diabetes Coordinator Act of 2008
S. 2983, Diabetes Prevention Access and Care Act of 2008
S. 1494, Reauthorization for special diabetes programs for Type I diabetes and Indians
H.R. 2210, Diabetes Prevention Access and Care Act of 2007
H.R. 2762, Reauthorization for special diabetes programs for Type I diabetes and Indians
H.R. 3544, Catalyst for Better Diabetes Care Act of 2007
H.R. 4836, National Diabetes Coordinator Act of 2008
H.R. 2922, Preventing Diabetes in Medicare Act of 2007
H.R. 3014, Health Equity and Accountability Act of 2007
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
H.R.2762/S.1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians
H.R.4836, National Diabetes Coordinator Act of 2008
H.R. 493/S.358, Genetic Information Nondiscrimination Act of 2007 H.R.6331/S.3101/S.3118, Medicare Improvements for Patients and Providers Act of 2008
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs
Client expense: $350,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Cited source text, amounts, lobbyists, and targets
Reauthorization of the Special Diabetes Program for Indians and the Special Statutory Funding Program for Type 1 Diabetes research, through S.1494 and H.R.2762, bills to amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians, or through Medicare legislation taken up in the House and Senate (HR 6331; S. 3101).
Client expense: Not reported · Firm income: $30,000
Cited source text, amounts, lobbyists, and targets
H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions; H.R. 2349/ S. 1413 "To provide research and education with respect to uterine fibroids, and for other purposes", regarding all provisions.
Client expense: $1,700,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H. R. 6133, Medicare Improvements for Patients and Providers Act of 2008.
Support Sec. 303. Extension of Special Diabetes Grant Programs: Extends the Special Diabetes Program for Indians at the Indian Health Service and the Special Statutory Funding for type 1 Research at the National Institutes of Health each for 2 additional years. Additionally supported Sec. 185 provision to addressing health disparities. (previously H.R. 2762/S. 1494)
Client expense: $335,500 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
**see addendum page S. 1494/H.R. 2762 - To amend the Public Health Service Act to reauthorize the special diabetes programs for Type 1 diabetes
and Indians under the Act, Funding of Type 1 Diabetes
***, no specific bill(s), Artifical Pancreas, Critical Path
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions.
Client expense: $1,440,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.2762/S.1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians
H.R.4836, National Diabetes Coordinator Act of 2008
H.R. 493/S.358, Genetic Information Nondiscrimination Act of 2007
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Cited source text, amounts, lobbyists, and targets
Reauthorization of the Special Diabetes Program for Indians and the Special Statutory Funding Program for Type 1 Diabetes research, through S.1494 and H.R.2762, bills to amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians, or through Medicare legislation taken up in the House and Senate.
Client expense: Not reported · Firm income: $30,000
Cited source text, amounts, lobbyists, and targets
H.R. 2762/S. 1494, Special Diabetes Programs Reauthorization Support entire bill: Extends the Special Diabetes Program for Indians at the Indian Health Service and the Special Statutory Funding for type 1 Research at the National Institutes of Health each for 5 additional years and increases funding for each program.
Client expense: $145,500 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
*see addendum page S. 1494/H.R. 2762 - To amend the Public Health Service Act to reauthorize the special diabetes programs for Type 1 diabetes and Indians under that Act, Funding of Type 1 Diabetes
***, no specific bill(s), Artifical Pancreas
H.R. 3/S. 5 - Stem Cell Research Enhancement Act of 2007
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Cited source text, amounts, lobbyists, and targets
HR 2762 / S 1494, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act, regarding all provisions.
Client expense: $3,880,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
S. 1494/H.R. 2762 - To amend the Public Health Service Act to reauthorize the special diabetes programs for Type 1 diabetes and Indians under that Act, Funding of Type 1 Diabetes
***, no specific bill(s), Artificial Pancreas
Client expense: Not reported · Firm income: $120,000
Cited source text, amounts, lobbyists, and targets
S. 1494/H.R. 2762 - To amend the Public Health Service Act to reauthorize the special diabetes programs for Type 1 diabetes and Indians under that Act, Funding of Type 1 Diabetes
***, no specific bill(s), Artificial Pancreas
Client expense: Not reported · Firm income: $120,000
Cited source text, amounts, lobbyists, and targets
H.R. 2762/S. 1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians
H.R.3162, Childrens Health and Medicare Protection Act of 2007
S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007
Client expense: $340,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, UNDETERMINED
Cited source text, amounts, lobbyists, and targets
HR 2762 / S 1494, “To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act,” all provisions; S 976, "Genomics and Personalized Medicine Act of 2007," all provisions; S 736, "Laboratory Test Improvement Act," all provisions.
Client expense: $3,820,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
*
S. 755, Diabetes Screening and Medicaid Savings Act
H.R. 2762, S 1494, Reauthorization of Special Diabetes Funding for Type 1 Diabetes and Indians
S. 631, Remote Patient Management for Diabetes and Other Chronic Health Care Conditions
H.R. 1224, Physical Education Content and Performance Standards in Schools
H.R. 2210, Diabetes Prevention Access and Care Act
H.R. 2922, Preventing Diabetes in Medicare Act
S. 1161, HELP America bill, pre-diabetes medicare provisions
H.R. 2241, S. 1391, Diabetes Treatment and Prevention Act
S. 242, H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007
H.R. 1038, S. 623, Access to Life-Saving Medicine Act, follow-on biologics
H.R. 1956, Patient Protection and innovative Biologic Medicines Act of 2007, follow-on biologics
S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics
S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics
5
6
Client expense: $300,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
HR 245 -Legislation for treating certain amounts paid for exercise equipment and physical fitness programs as amounts paid for medical treatment, for tax purposes.
S 999/ HR 477 -Stroke Treatment and Ongoing Prevention (STOP) Act.
HR 1283-Arthritis Prevention, Control, and Cure Act.
HR 1418 - Expansion and improvement of traumatic brain injury programs.
HR 2762-Amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act.
S 646 - Rural Nursing Promotion Act, includes provision to report on the source of newly licensed PTs in the US.
HR 1368 - Provide financial incentives to adoption and use of interactive personal health records.
HR 1952 - Financial incentives for purchase of Health IT by small health care providers and entities.
S 638 - Grants for rural health IT development activities.
S 1183 / HR 1727 - Christopher and Dana Reeve Paralysis Act.
HR 15 - National Health Insurance Program.
HR 241 - Small business health fairness Act association health plans.
S 325 / HR 506- Program to foster innovation in health care through state initiatives.
HR 636 - Tax deductibility of medical expenses.
HR 676 - Comprehensive health coverage for all US residents.
HR 1200- American Health Security Act.
HR 1841 - AmeriCare universal health care program.
S 46 - Expand HSA use.
S 334 - Provide affordable guaranteed private health coverage for all Americans.
S 733 - Provide grants to self insured businesses to form health care cooperatives.
S 1019 - Universal Health Care Choice and Access Act.
S 1198 - Determine successful methods to protect against catastrophic health care costs exceeding insurance.
S 793 - Expansion and improvement of traumatic brain injury programs.
S 845- Keeping Seniors Safe from Falls Act of 2007.
S 0866 - Health Promotion Funding Integrated Research, Synthesis, and Training Act (Health Promotion FIRST Act).
S 1050 - Establish a program for wellness and prevention of secondary conditions for individuals with disabilities.
HR 979 - Patient bill of rights.
HR 1134- NHSC Student Loan Repayment - Legislation to include physical therapists in the National Health Service Corps for the purpose of student loan repayment.
HR 446 - Legislation to further research into paralysis and improve rehabilitation for sufferers.
HCR 91- Resolution for further research into paralysis and improving quality of life for sufferers.
Cited source text, amounts, lobbyists, and targets
S.1893,Children's Health Insurance Program Reauthorization Act of 2007
H.R.2564/S.1036,Human Cloning Prohibition Act of 2007
S.812, Human Cloning Ban and Stem Cell Research Protection Act of 2007
S.30,Hope Offered through Principled and Ethical Stem Cell Research Act
H.R.3/S.5,Stem Cell Research Enhancement Act of 2007
H.R.2762/S.1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians
H.R.3162,Children's Health and Medicare Protection Act of 2007
Client expense: $460,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 3/S. 5 - Stem Cell Research Enhancement Act of 2007
S. 1494/H.R. 2762 - To amend the Public Health Service Act to reauthorize the special diabetes programs for Type 1 diabetes and Indians under that Act, Funding of Type 1 Diabetes
***, no specific bill(s), Artificial Pancreas
Client expense: Not reported · Firm income: $60,000
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Client expense: $857,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE